Detox at home: what the guidelines actually allow

Some people can go through withdrawal at home, but under the guidelines that means outpatient detox run by a clinician, not stopping alone. ASAM’s 2020 alcohol guideline says withdrawal can typically be managed safely outside a hospital “for those patients with limited or mitigated risk factors.” Whether that’s you is a call a clinician makes after assessing you. Alcohol and benzodiazepines are the two where getting it wrong can kill.

Call 911, at home or anywhere, if

• There’s a seizure.
• Someone becomes confused or doesn’t know where they are.
• They’re seeing or hearing things and seem disoriented.
• They faint, or are so drowsy they can’t be woken properly.
• Breathing is very slow or has stopped (give naloxone first if opioids may be involved).
• They talk about harming themselves.

What “outpatient detox” means in the guidelines

ASAM describes two outpatient (ambulatory) levels for alcohol withdrawal:

• Level 1-WM, without extended on-site monitoring. It can be carried out in a physician’s office, by a home health agency or at an addiction treatment facility. You go home between visits.
• Level 2-WM, with extended on-site monitoring, like a day hospital. You spend hours there being checked, then go home.

In both, a clinician is in charge. ASAM’s outpatient protocol includes daily check-ins with a qualified provider for up to five days after you stop, a standard severity scale, medication when it’s indicated, and a plan to move you to a higher level of care if things get worse. The clinician’s plan also covers home: it teaches you and your support person what signs of worsening withdrawal to watch for, and it tells you to keep the home calm and low-stimulation and to drink non-caffeinated fluids.

That’s very different from deciding on your own to stop this weekend.

Who may be managed as an outpatient for alcohol

From ASAM’s Table 2, Level 1-WM fits mild withdrawal (a CIWA-Ar score under 10). It’s considered inappropriate if any of these apply:

• Severe or complicated withdrawal (a CIWA-Ar of 19 or more, or a seizure, delirium or new hallucinations)
• Physical dependence on benzodiazepines, or a benzodiazepine use disorder
• A recent complicated withdrawal
• A moderate to severe medical problem that could destabilize
• A possible head injury
• Being unable to take medication by mouth
• Moderate or severe psychiatric symptoms or cognitive impairment
• Imminent risk of harm to self or others

Level 2-WM stretches further, to mild or moderate withdrawal (CIWA-Ar under 18). Severe but uncomplicated withdrawal is listed as uncertain. Complicated withdrawal is inappropriate. ASAM’s rule: if anything that rules out Level 2-WM is present, the person should be managed in an inpatient setting.

Some factors sit in the gray zone for both outpatient levels:

• Drinking more than 8 standard drinks a day
• Older age
• A history of epilepsy
• No reliable caregiver
• No reliable support network

Low support or an unsafe home may mean a more intensive level of care is better, ASAM says. And active suicide risk often means admission to an inpatient psychiatric setting.

The full list of alcohol risk factors, and the timeline, are in our alcohol withdrawal guide.

Why alcohol and benzodiazepines are the risky ones

Withdrawal from both can cause seizures. Alcohol withdrawal can also cause delirium tremens, and even with medical care 1 to 5 percent of DT episodes end in death, according to the 2015 Drugs review (Mirijello) and the 2004 American Family Physician review. For benzodiazepines, the FDA warns that stopping abruptly or cutting the dose fast can bring on withdrawal reactions that can be life-threatening.

Opioid and stimulant withdrawal are different. TIP 45 says uncomplicated opioid withdrawal is not life-threatening, and stimulant withdrawal is not usually tied to medical complications. They carry other risks, covered in the next section.

Why “cold turkey” alone isn’t recommended

Alcohol. TIP 45 says the indications for managing alcohol withdrawal without medication “have not been established through scientific studies,” and that “it is impossible to tell who will or will not experience life-threatening complications.” Seizures can come without warning signs.

Benzodiazepines. The 2025 joint tapering guideline tells clinicians not to stop them abruptly in people likely to be physically dependent. The answer is a slow taper with your prescriber. See benzodiazepine withdrawal.

Opioids. ASAM recommends methadone or buprenorphine over abrupt stopping, and TIP 45 advises against managing significant opioid withdrawal without effective medication. The danger isn’t usually withdrawal itself. It’s overdose afterward, once tolerance is gone. See opioid withdrawal.

Stimulants. There’s no medication for the withdrawal, so the work is watching mood. Amphetamine withdrawal in particular can bring longer, deeper depression, and TIP 45 says people should be monitored for suicidality. See stimulant withdrawal.

If you use more than one substance, the riskiest one sets the plan.

How to get assessed fast

You don’t need to figure out your level of care yourself. You need someone qualified to look at you, ideally today.

1. Call the SAMHSA National Helpline: 1-800-662-HELP (4357). It’s free, confidential and open 24/7, in English and Spanish. It gives referrals to local treatment facilities, support groups and community organizations; it doesn’t provide counseling. TTY: 1-800-487-4889. You can also text your ZIP code to 435748 (HELP4U), in English only.
2. Call your primary care clinician. Say you want to stop drinking (or using) and need a withdrawal assessment. Tell them how much and how often, any past seizures or hard withdrawals, and what else you take.
3. Use the finder. Enter your ZIP in the finder to see withdrawal management programs near you from every withdrawal management program SAMHSA lists, or browse by state at /detox/. Call one and ask whether they can assess you today, and whether they offer outpatient or inpatient withdrawal management.

Be honest with whoever assesses you. The plan is only as safe as the information it’s built on.

Sources

• ASAM, The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management, J Addict Med, 2020 (adopted Jan 23, 2020)
• SAMHSA, Quick Guide for Clinicians Based on TIP 45: Detoxification and Substance Abuse Treatment, based on TIP 45 (2006)
• ASAM, The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update, J Addict Med, released Mar 2020
• Brunner E, et al. Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits, J Gen Intern Med, 2025 (epub Jun 17, 2025)
• FDA-approved alprazolam label, Boxed Warning, label effective Jan 3, 2025
• Mirijello A, et al. Identification and management of alcohol withdrawal syndrome, Drugs, 2015
• Bayard M, et al. Alcohol Withdrawal Syndrome, Am Fam Physician, Mar 15, 2004
• SAMHSA National Helpline, last updated Jun 9, 2023